CARBENDAZIM
UNII H75J14AA89

Substance Identification & Data

This profile provides standardized clinical and technical data for Carbendazim, uniquely identified by the FDA Unique Ingredient Identifier (UNII) H75J14AA89.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 10605-21-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

H75J14AA89

CAS Registry Number

10605-21-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

CARBENDAZIM

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C9H9N3O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

TWFZGCMQGLPBSX-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C1154

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

25429

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1(nc2ccccc2[nH]1)NC(=O)OC

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Carbendazim. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.